Poland
· Delayed Price · Currency is PLN Hemp & Health Statistics
Total Valuation
Hemp & Health has a market cap or net worth of PLN 20.18 million. The enterprise value is 15.57 million.
| Market Cap | 20.18M |
| Enterprise Value | 15.57M |
Important Dates
The next estimated earnings date is Wednesday, February 12, 2025.
| Earnings Date | Feb 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Hemp & Health has 72.31 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 72.31M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 13.15% |
| Owned by Institutions (%) | n/a |
| Float | 59.49M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 80.26 |
| PB Ratio | 4.18 |
| P/TBV Ratio | 4.18 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -438.47 |
| EV / Sales | 61.92 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 86.44
| Current Ratio | 86.44 |
| Quick Ratio | 85.24 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,099.04 |
Financial Efficiency
Return on equity (ROE) is -0.86% and return on invested capital (ROIC) is -9.57%.
| Return on Equity (ROE) | -0.86% |
| Return on Assets (ROA) | -9.30% |
| Return on Capital (ROIC) | -9.57% |
| Revenue Per Employee | 83,807 |
| Profits Per Employee | -11,835 |
| Employee Count | 3 |
| Asset Turnover | 0.06 |
| Inventory Turnover | 2.00 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +3.64% in the last 52 weeks. The beta is -1.32, so Hemp & Health's price volatility has been lower than the market average.
| Beta (5Y) | -1.32 |
| 52-Week Price Change | +3.64% |
| 50-Day Moving Average | 0.30 |
| 200-Day Moving Average | 0.40 |
| Relative Strength Index (RSI) | 50.14 |
| Average Volume (20 Days) | 450,748 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Hemp & Health had revenue of PLN 251,421 and -35,504 in losses. Loss per share was -0.00.
| Revenue | 251,421 |
| Gross Profit | -41,460 |
| Operating Income | -634,146 |
| Pretax Income | -35,504 |
| Net Income | -35,504 |
| EBITDA | -594,924 |
| EBIT | -634,146 |
| Loss Per Share | -0.00 |
Balance Sheet
| Cash & Cash Equivalents | 4.61M |
| Total Debt | n/a |
| Net Cash | 4.61M |
| Net Cash Per Share | 0.06 |
| Equity (Book Value) | 4.83M |
| Book Value Per Share | 0.07 |
| Working Capital | 4.68M |
Cash Flow
| Operating Cash Flow | -399,438 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is -16.49%, with operating and profit margins of -252.22% and -14.12%.
| Gross Margin | -16.49% |
| Operating Margin | -252.22% |
| Pretax Margin | -14.12% |
| Profit Margin | -14.12% |
| EBITDA Margin | -236.62% |
| EBIT Margin | -252.22% |
| FCF Margin | n/a |
Dividends & Yields
Hemp & Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -0.18% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Hemp & Health has an Altman Z-Score of 282.32.
| Altman Z-Score | 282.32 |
| Piotroski F-Score | n/a |